nodes	percent_of_prediction	percent_of_DWPC	metapath
Ponatinib—ABCB11—Cimetidine—obesity	0.119	0.271	CbGbCtD
Ponatinib—CYP2C8—Bupropion—obesity	0.0412	0.0936	CbGbCtD
Ponatinib—CYP3A5—Cimetidine—obesity	0.0314	0.0715	CbGbCtD
Ponatinib—CYP2D6—Phentermine—obesity	0.0309	0.0702	CbGbCtD
Ponatinib—CYP2C8—Cimetidine—obesity	0.0302	0.0687	CbGbCtD
Ponatinib—CYP2D6—Bupropion—obesity	0.0263	0.0597	CbGbCtD
Ponatinib—CYP3A4—Sibutramine—obesity	0.0259	0.0589	CbGbCtD
Ponatinib—CYP2D6—Methamphetamine—obesity	0.0247	0.0561	CbGbCtD
Ponatinib—ABCB1—Cimetidine—obesity	0.0205	0.0465	CbGbCtD
Ponatinib—CYP3A4—Benzphetamine—obesity	0.0196	0.0446	CbGbCtD
Ponatinib—CYP2D6—Cimetidine—obesity	0.0193	0.0438	CbGbCtD
Ponatinib—CYP3A4—Bupropion—obesity	0.0167	0.038	CbGbCtD
Ponatinib—CYP3A4—Orlistat—obesity	0.0136	0.0309	CbGbCtD
Ponatinib—CYP3A4—Cimetidine—obesity	0.0123	0.0279	CbGbCtD
Ponatinib—CYP3A4—Topiramate—obesity	0.00802	0.0182	CbGbCtD
Ponatinib—ABCB11—bile—obesity	0.00763	0.064	CbGeAlD
Ponatinib—RET—autonomic nervous system—obesity	0.00521	0.0438	CbGeAlD
Ponatinib—FGFR4—hindbrain—obesity	0.00467	0.0392	CbGeAlD
Ponatinib—FGFR4—respiratory system—obesity	0.00285	0.0239	CbGeAlD
Ponatinib—Nilotinib—CA3—obesity	0.00267	0.355	CrCbGaD
Ponatinib—Imatinib—CA3—obesity	0.00223	0.296	CrCbGaD
Ponatinib—FGFR2—hindbrain—obesity	0.00209	0.0175	CbGeAlD
Ponatinib—Nilotinib—MAPK8—obesity	0.00195	0.259	CrCbGaD
Ponatinib—FGFR3—respiratory system—obesity	0.00195	0.0163	CbGeAlD
Ponatinib—FGFR4—pituitary gland—obesity	0.00194	0.0162	CbGeAlD
Ponatinib—FGFR4—digestive system—obesity	0.00181	0.0152	CbGeAlD
Ponatinib—PDGFRA—gall bladder—obesity	0.00179	0.015	CbGeAlD
Ponatinib—BCR—islet of Langerhans—obesity	0.00178	0.015	CbGeAlD
Ponatinib—FGFR4—adrenal gland—obesity	0.00173	0.0145	CbGeAlD
Ponatinib—BCR—respiratory system—obesity	0.00168	0.0141	CbGeAlD
Ponatinib—FLT3—respiratory system—obesity	0.00167	0.014	CbGeAlD
Ponatinib—FGFR4—endocrine gland—obesity	0.0015	0.0126	CbGeAlD
Ponatinib—KIT—hindbrain—obesity	0.00145	0.0122	CbGeAlD
Ponatinib—KIT—gall bladder—obesity	0.00143	0.012	CbGeAlD
Ponatinib—BCR—adrenal cortex—obesity	0.00141	0.0119	CbGeAlD
Ponatinib—FGFR4—liver—obesity	0.00135	0.0113	CbGeAlD
Ponatinib—FLT3—cardiovascular system—obesity	0.00128	0.0108	CbGeAlD
Ponatinib—FGFR2—respiratory system—obesity	0.00127	0.0107	CbGeAlD
Ponatinib—ABL1—hindbrain—obesity	0.00126	0.0106	CbGeAlD
Ponatinib—TEK—respiratory system—obesity	0.00122	0.0103	CbGeAlD
Ponatinib—FGFR3—adrenal gland—obesity	0.00118	0.0099	CbGeAlD
Ponatinib—SRC—islet of Langerhans—obesity	0.00115	0.00965	CbGeAlD
Ponatinib—BCR—pituitary gland—obesity	0.00114	0.00959	CbGeAlD
Ponatinib—BCR—adipose tissue—obesity	0.00114	0.00955	CbGeAlD
Ponatinib—PDGFRA—respiratory system—obesity	0.00111	0.00929	CbGeAlD
Ponatinib—SRC—respiratory system—obesity	0.00109	0.00911	CbGeAlD
Ponatinib—LYN—endocrine gland—obesity	0.00103	0.00863	CbGeAlD
Ponatinib—TEK—adrenal cortex—obesity	0.00103	0.00861	CbGeAlD
Ponatinib—FGFR3—endocrine gland—obesity	0.00102	0.00858	CbGeAlD
Ponatinib—BCR—adrenal gland—obesity	0.00102	0.00856	CbGeAlD
Ponatinib—FGFR1—pituitary gland—obesity	0.00102	0.00853	CbGeAlD
Ponatinib—FLT3—adrenal gland—obesity	0.00101	0.0085	CbGeAlD
Ponatinib—FGFR1—adipose tissue—obesity	0.00101	0.0085	CbGeAlD
Ponatinib—KDR—respiratory system—obesity	0.000999	0.00838	CbGeAlD
Ponatinib—FGFR2—cardiovascular system—obesity	0.000976	0.00819	CbGeAlD
Ponatinib—TEK—cardiovascular system—obesity	0.000936	0.00785	CbGeAlD
Ponatinib—LYN—liver—obesity	0.000927	0.00778	CbGeAlD
Ponatinib—FGFR3—liver—obesity	0.000922	0.00774	CbGeAlD
Ponatinib—RET—pituitary gland—obesity	0.00091	0.00763	CbGeAlD
Ponatinib—FGFR1—adrenal gland—obesity	0.000908	0.00762	CbGeAlD
Ponatinib—LCK—adipose tissue—obesity	0.000906	0.0076	CbGeAlD
Ponatinib—BCR—endocrine gland—obesity	0.000885	0.00743	CbGeAlD
Ponatinib—KIT—respiratory system—obesity	0.000885	0.00743	CbGeAlD
Ponatinib—FLT3—endocrine gland—obesity	0.000879	0.00737	CbGeAlD
Ponatinib—FGFR2—adipose tissue—obesity	0.000861	0.00722	CbGeAlD
Ponatinib—RET—digestive system—obesity	0.000853	0.00716	CbGeAlD
Ponatinib—PDGFRA—cardiovascular system—obesity	0.000848	0.00711	CbGeAlD
Ponatinib—KDR—adrenal cortex—obesity	0.000838	0.00703	CbGeAlD
Ponatinib—ABCB11—digestive system—obesity	0.000833	0.00699	CbGeAlD
Ponatinib—SRC—cardiovascular system—obesity	0.000832	0.00698	CbGeAlD
Ponatinib—TEK—pituitary gland—obesity	0.000829	0.00695	CbGeAlD
Ponatinib—TEK—adipose tissue—obesity	0.000825	0.00693	CbGeAlD
Ponatinib—ABL1—islet of Langerhans—obesity	0.000816	0.00685	CbGeAlD
Ponatinib—RET—adrenal gland—obesity	0.000813	0.00682	CbGeAlD
Ponatinib—LCK—adrenal gland—obesity	0.000813	0.00682	CbGeAlD
Ponatinib—FGFR2—digestive system—obesity	0.00081	0.0068	CbGeAlD
Ponatinib—BCR—liver—obesity	0.000798	0.0067	CbGeAlD
Ponatinib—FLT3—liver—obesity	0.000792	0.00665	CbGeAlD
Ponatinib—FGFR2—adrenal gland—obesity	0.000772	0.00648	CbGeAlD
Ponatinib—ABL1—respiratory system—obesity	0.000771	0.00646	CbGeAlD
Ponatinib—KDR—cardiovascular system—obesity	0.000765	0.00642	CbGeAlD
Ponatinib—PDGFRA—adipose tissue—obesity	0.000748	0.00627	CbGeAlD
Ponatinib—TEK—adrenal gland—obesity	0.00074	0.00621	CbGeAlD
Ponatinib—SRC—adipose tissue—obesity	0.000733	0.00615	CbGeAlD
Ponatinib—FGFR1—liver—obesity	0.00071	0.00596	CbGeAlD
Ponatinib—RET—endocrine gland—obesity	0.000705	0.00591	CbGeAlD
Ponatinib—PDGFRA—digestive system—obesity	0.000704	0.00591	CbGeAlD
Ponatinib—SRC—digestive system—obesity	0.00069	0.00579	CbGeAlD
Ponatinib—ABCB11—endocrine gland—obesity	0.000688	0.00578	CbGeAlD
Ponatinib—KIT—cardiovascular system—obesity	0.000678	0.00569	CbGeAlD
Ponatinib—KDR—pituitary gland—obesity	0.000677	0.00568	CbGeAlD
Ponatinib—KDR—adipose tissue—obesity	0.000675	0.00566	CbGeAlD
Ponatinib—PDGFRA—adrenal gland—obesity	0.000671	0.00563	CbGeAlD
Ponatinib—FGFR2—endocrine gland—obesity	0.00067	0.00562	CbGeAlD
Ponatinib—SRC—adrenal gland—obesity	0.000658	0.00552	CbGeAlD
Ponatinib—ABL1—adrenal cortex—obesity	0.000647	0.00543	CbGeAlD
Ponatinib—TEK—endocrine gland—obesity	0.000642	0.00539	CbGeAlD
Ponatinib—LCK—liver—obesity	0.000635	0.00533	CbGeAlD
Ponatinib—KDR—digestive system—obesity	0.000635	0.00533	CbGeAlD
Ponatinib—ABCB11—liver—obesity	0.000621	0.00521	CbGeAlD
Ponatinib—KDR—adrenal gland—obesity	0.000605	0.00508	CbGeAlD
Ponatinib—FGFR2—liver—obesity	0.000604	0.00507	CbGeAlD
Ponatinib—KIT—pituitary gland—obesity	0.0006	0.00504	CbGeAlD
Ponatinib—KIT—adipose tissue—obesity	0.000598	0.00502	CbGeAlD
Ponatinib—ABL1—cardiovascular system—obesity	0.00059	0.00495	CbGeAlD
Ponatinib—PDGFRA—endocrine gland—obesity	0.000582	0.00488	CbGeAlD
Ponatinib—TEK—liver—obesity	0.000579	0.00486	CbGeAlD
Ponatinib—SRC—endocrine gland—obesity	0.00057	0.00479	CbGeAlD
Ponatinib—KIT—digestive system—obesity	0.000563	0.00472	CbGeAlD
Ponatinib—CYP2D6—hindbrain—obesity	0.000545	0.00458	CbGeAlD
Ponatinib—KIT—adrenal gland—obesity	0.000536	0.0045	CbGeAlD
Ponatinib—Imatinib—SLC22A1—obesity	0.000525	0.0696	CrCbGaD
Ponatinib—KDR—endocrine gland—obesity	0.000525	0.0044	CbGeAlD
Ponatinib—PDGFRA—liver—obesity	0.000524	0.0044	CbGeAlD
Ponatinib—ABL1—pituitary gland—obesity	0.000523	0.00438	CbGeAlD
Ponatinib—ABL1—adipose tissue—obesity	0.00052	0.00437	CbGeAlD
Ponatinib—SRC—liver—obesity	0.000514	0.00431	CbGeAlD
Ponatinib—ABL1—digestive system—obesity	0.00049	0.00411	CbGeAlD
Ponatinib—CYP3A5—islet of Langerhans—obesity	0.000478	0.00401	CbGeAlD
Ponatinib—KDR—liver—obesity	0.000473	0.00397	CbGeAlD
Ponatinib—ABL1—adrenal gland—obesity	0.000467	0.00392	CbGeAlD
Ponatinib—KIT—endocrine gland—obesity	0.000465	0.0039	CbGeAlD
Ponatinib—CYP3A5—respiratory system—obesity	0.000451	0.00378	CbGeAlD
Ponatinib—KIT—liver—obesity	0.000419	0.00352	CbGeAlD
Ponatinib—ABCG2—adrenal cortex—obesity	0.000408	0.00342	CbGeAlD
Ponatinib—ABL1—endocrine gland—obesity	0.000405	0.0034	CbGeAlD
Ponatinib—ABL1—liver—obesity	0.000365	0.00306	CbGeAlD
Ponatinib—CYP2C8—pituitary gland—obesity	0.000339	0.00284	CbGeAlD
Ponatinib—Weight decreased—Bupropion—obesity	0.000334	0.00183	CcSEcCtD
Ponatinib—Oedema peripheral—Sibutramine—obesity	0.000334	0.00183	CcSEcCtD
Ponatinib—Hyperglycaemia—Bupropion—obesity	0.000333	0.00183	CcSEcCtD
Ponatinib—Pneumonia—Bupropion—obesity	0.000331	0.00182	CcSEcCtD
Ponatinib—ABCG2—pituitary gland—obesity	0.00033	0.00276	CbGeAlD
Ponatinib—Infestation—Bupropion—obesity	0.000329	0.00181	CcSEcCtD
Ponatinib—Infestation NOS—Bupropion—obesity	0.000329	0.00181	CcSEcCtD
Ponatinib—ABCG2—adipose tissue—obesity	0.000328	0.00275	CbGeAlD
Ponatinib—Visual impairment—Sibutramine—obesity	0.000327	0.00179	CcSEcCtD
Ponatinib—Acute coronary syndrome—Bupropion—obesity	0.000325	0.00178	CcSEcCtD
Ponatinib—Diarrhoea—Diethylpropion—obesity	0.000324	0.00178	CcSEcCtD
Ponatinib—Nausea—Phentermine—obesity	0.000324	0.00178	CcSEcCtD
Ponatinib—Asthenia—Cimetidine—obesity	0.000323	0.00178	CcSEcCtD
Ponatinib—Myocardial infarction—Bupropion—obesity	0.000323	0.00177	CcSEcCtD
Ponatinib—Neuropathy peripheral—Bupropion—obesity	0.000323	0.00177	CcSEcCtD
Ponatinib—Jaundice—Bupropion—obesity	0.000321	0.00176	CcSEcCtD
Ponatinib—Stomatitis—Bupropion—obesity	0.000321	0.00176	CcSEcCtD
Ponatinib—Urinary tract infection—Bupropion—obesity	0.00032	0.00176	CcSEcCtD
Ponatinib—Eye disorder—Sibutramine—obesity	0.000317	0.00174	CcSEcCtD
Ponatinib—Mediastinal disorder—Orlistat—obesity	0.000316	0.00173	CcSEcCtD
Ponatinib—Dizziness—Diethylpropion—obesity	0.000313	0.00172	CcSEcCtD
Ponatinib—Blood alkaline phosphatase increased—Topiramate—obesity	0.000313	0.00172	CcSEcCtD
Ponatinib—Epistaxis—Bupropion—obesity	0.000311	0.00171	CcSEcCtD
Ponatinib—Alopecia—Orlistat—obesity	0.00031	0.0017	CcSEcCtD
Ponatinib—Diarrhoea—Cimetidine—obesity	0.000308	0.00169	CcSEcCtD
Ponatinib—Angiopathy—Sibutramine—obesity	0.000308	0.00169	CcSEcCtD
Ponatinib—Mental disorder—Orlistat—obesity	0.000307	0.00169	CcSEcCtD
Ponatinib—Malnutrition—Orlistat—obesity	0.000305	0.00167	CcSEcCtD
Ponatinib—CYP3A5—adipose tissue—obesity	0.000305	0.00256	CbGeAlD
Ponatinib—Chills—Sibutramine—obesity	0.000304	0.00167	CcSEcCtD
Ponatinib—Arrhythmia—Sibutramine—obesity	0.000303	0.00166	CcSEcCtD
Ponatinib—Vomiting—Diethylpropion—obesity	0.000301	0.00165	CcSEcCtD
Ponatinib—Alopecia—Sibutramine—obesity	0.0003	0.00165	CcSEcCtD
Ponatinib—Rash—Diethylpropion—obesity	0.000299	0.00164	CcSEcCtD
Ponatinib—Dermatitis—Diethylpropion—obesity	0.000298	0.00164	CcSEcCtD
Ponatinib—Dizziness—Cimetidine—obesity	0.000298	0.00164	CcSEcCtD
Ponatinib—Haemoglobin—Bupropion—obesity	0.000297	0.00163	CcSEcCtD
Ponatinib—Headache—Diethylpropion—obesity	0.000297	0.00163	CcSEcCtD
Ponatinib—Haemorrhage—Bupropion—obesity	0.000296	0.00162	CcSEcCtD
Ponatinib—Malnutrition—Sibutramine—obesity	0.000295	0.00162	CcSEcCtD
Ponatinib—Back pain—Orlistat—obesity	0.000295	0.00162	CcSEcCtD
Ponatinib—ABCG2—adrenal gland—obesity	0.000294	0.00247	CbGeAlD
Ponatinib—Hypoaesthesia—Bupropion—obesity	0.000294	0.00161	CcSEcCtD
Ponatinib—Muscle spasms—Orlistat—obesity	0.000293	0.00161	CcSEcCtD
Ponatinib—Oedema peripheral—Bupropion—obesity	0.000291	0.0016	CcSEcCtD
Ponatinib—Hot flush—Topiramate—obesity	0.000291	0.0016	CcSEcCtD
Ponatinib—Connective tissue disorder—Bupropion—obesity	0.00029	0.00159	CcSEcCtD
Ponatinib—Menopausal symptoms—Topiramate—obesity	0.000288	0.00158	CcSEcCtD
Ponatinib—Vision blurred—Orlistat—obesity	0.000287	0.00158	CcSEcCtD
Ponatinib—CYP3A5—digestive system—obesity	0.000287	0.00241	CbGeAlD
Ponatinib—Vomiting—Cimetidine—obesity	0.000287	0.00157	CcSEcCtD
Ponatinib—Back pain—Sibutramine—obesity	0.000286	0.00157	CcSEcCtD
Ponatinib—Visual impairment—Bupropion—obesity	0.000285	0.00156	CcSEcCtD
Ponatinib—Rash—Cimetidine—obesity	0.000284	0.00156	CcSEcCtD
Ponatinib—Dermatitis—Cimetidine—obesity	0.000284	0.00156	CcSEcCtD
Ponatinib—Muscle spasms—Sibutramine—obesity	0.000284	0.00156	CcSEcCtD
Ponatinib—Headache—Cimetidine—obesity	0.000282	0.00155	CcSEcCtD
Ponatinib—Nausea—Diethylpropion—obesity	0.000281	0.00155	CcSEcCtD
Ponatinib—Vision blurred—Sibutramine—obesity	0.000278	0.00153	CcSEcCtD
Ponatinib—Lethargy—Topiramate—obesity	0.000278	0.00153	CcSEcCtD
Ponatinib—Eye disorder—Bupropion—obesity	0.000276	0.00152	CcSEcCtD
Ponatinib—Flushing—Bupropion—obesity	0.000274	0.00151	CcSEcCtD
Ponatinib—Cardiac disorder—Bupropion—obesity	0.000274	0.00151	CcSEcCtD
Ponatinib—Hyponatraemia—Topiramate—obesity	0.000273	0.0015	CcSEcCtD
Ponatinib—Anaemia—Sibutramine—obesity	0.000273	0.0015	CcSEcCtD
Ponatinib—Pain in extremity—Topiramate—obesity	0.000272	0.00149	CcSEcCtD
Ponatinib—Angiopathy—Bupropion—obesity	0.000268	0.00147	CcSEcCtD
Ponatinib—Migraine—Topiramate—obesity	0.000268	0.00147	CcSEcCtD
Ponatinib—Nausea—Cimetidine—obesity	0.000268	0.00147	CcSEcCtD
Ponatinib—Mediastinal disorder—Bupropion—obesity	0.000266	0.00146	CcSEcCtD
Ponatinib—Cough—Orlistat—obesity	0.000266	0.00146	CcSEcCtD
Ponatinib—Chills—Bupropion—obesity	0.000265	0.00146	CcSEcCtD
Ponatinib—Leukopenia—Sibutramine—obesity	0.000264	0.00145	CcSEcCtD
Ponatinib—Arrhythmia—Bupropion—obesity	0.000264	0.00145	CcSEcCtD
Ponatinib—Face oedema—Topiramate—obesity	0.000263	0.00144	CcSEcCtD
Ponatinib—CYP2C8—endocrine gland—obesity	0.000263	0.0022	CbGeAlD
Ponatinib—Alopecia—Bupropion—obesity	0.000261	0.00143	CcSEcCtD
Ponatinib—Myalgia—Orlistat—obesity	0.00026	0.00143	CcSEcCtD
Ponatinib—Mental disorder—Bupropion—obesity	0.000259	0.00142	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000258	0.00142	CcSEcCtD
Ponatinib—Cough—Sibutramine—obesity	0.000258	0.00141	CcSEcCtD
Ponatinib—Malnutrition—Bupropion—obesity	0.000257	0.00141	CcSEcCtD
Ponatinib—Blood creatinine increased—Topiramate—obesity	0.000255	0.0014	CcSEcCtD
Ponatinib—Hypertension—Sibutramine—obesity	0.000255	0.0014	CcSEcCtD
Ponatinib—Dry mouth—Orlistat—obesity	0.000254	0.00139	CcSEcCtD
Ponatinib—ABCB1—islet of Langerhans—obesity	0.000254	0.00213	CbGeAlD
Ponatinib—Dehydration—Topiramate—obesity	0.000253	0.00139	CcSEcCtD
Ponatinib—Myalgia—Sibutramine—obesity	0.000251	0.00138	CcSEcCtD
Ponatinib—Arthralgia—Sibutramine—obesity	0.000251	0.00138	CcSEcCtD
Ponatinib—Oedema—Orlistat—obesity	0.000249	0.00137	CcSEcCtD
Ponatinib—Back pain—Bupropion—obesity	0.000249	0.00137	CcSEcCtD
Ponatinib—Hypokalaemia—Topiramate—obesity	0.000248	0.00136	CcSEcCtD
Ponatinib—Muscle spasms—Bupropion—obesity	0.000247	0.00136	CcSEcCtD
Ponatinib—Infection—Orlistat—obesity	0.000247	0.00136	CcSEcCtD
Ponatinib—Breast disorder—Topiramate—obesity	0.000246	0.00135	CcSEcCtD
Ponatinib—Dry mouth—Sibutramine—obesity	0.000246	0.00135	CcSEcCtD
Ponatinib—Aspartate aminotransferase increased—Topiramate—obesity	0.000245	0.00135	CcSEcCtD
Ponatinib—Nervous system disorder—Orlistat—obesity	0.000244	0.00134	CcSEcCtD
Ponatinib—Nasopharyngitis—Topiramate—obesity	0.000243	0.00134	CcSEcCtD
Ponatinib—Vision blurred—Bupropion—obesity	0.000243	0.00133	CcSEcCtD
Ponatinib—Skin disorder—Orlistat—obesity	0.000242	0.00133	CcSEcCtD
Ponatinib—Oedema—Sibutramine—obesity	0.000241	0.00132	CcSEcCtD
Ponatinib—Hyperhidrosis—Orlistat—obesity	0.000241	0.00132	CcSEcCtD
Ponatinib—Alanine aminotransferase increased—Topiramate—obesity	0.00024	0.00132	CcSEcCtD
Ponatinib—ABCB1—respiratory system—obesity	0.00024	0.00201	CbGeAlD
Ponatinib—Infection—Sibutramine—obesity	0.000239	0.00131	CcSEcCtD
Ponatinib—Anaemia—Bupropion—obesity	0.000238	0.00131	CcSEcCtD
Ponatinib—CYP3A5—endocrine gland—obesity	0.000237	0.00199	CbGeAlD
Ponatinib—Abdominal distension—Topiramate—obesity	0.000237	0.0013	CcSEcCtD
Ponatinib—CYP2C8—liver—obesity	0.000237	0.00199	CbGeAlD
Ponatinib—Thrombocytopenia—Sibutramine—obesity	0.000236	0.00129	CcSEcCtD
Ponatinib—Skin disorder—Sibutramine—obesity	0.000234	0.00128	CcSEcCtD
Ponatinib—Hyperhidrosis—Sibutramine—obesity	0.000233	0.00128	CcSEcCtD
Ponatinib—Pancreatitis—Topiramate—obesity	0.000231	0.00127	CcSEcCtD
Ponatinib—Leukopenia—Bupropion—obesity	0.00023	0.00126	CcSEcCtD
Ponatinib—ABCG2—liver—obesity	0.00023	0.00193	CbGeAlD
Ponatinib—Angina pectoris—Topiramate—obesity	0.000229	0.00126	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Orlistat—obesity	0.000227	0.00125	CcSEcCtD
Ponatinib—Abdominal discomfort—Topiramate—obesity	0.000226	0.00124	CcSEcCtD
Ponatinib—Insomnia—Orlistat—obesity	0.000225	0.00124	CcSEcCtD
Ponatinib—Cough—Bupropion—obesity	0.000225	0.00123	CcSEcCtD
Ponatinib—Paraesthesia—Orlistat—obesity	0.000224	0.00123	CcSEcCtD
Ponatinib—Pancytopenia—Topiramate—obesity	0.000223	0.00123	CcSEcCtD
Ponatinib—Hypertension—Bupropion—obesity	0.000222	0.00122	CcSEcCtD
Ponatinib—Neutropenia—Topiramate—obesity	0.00022	0.00121	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Sibutramine—obesity	0.000219	0.00121	CcSEcCtD
Ponatinib—Dyspepsia—Orlistat—obesity	0.000219	0.0012	CcSEcCtD
Ponatinib—Arthralgia—Bupropion—obesity	0.000219	0.0012	CcSEcCtD
Ponatinib—Myalgia—Bupropion—obesity	0.000219	0.0012	CcSEcCtD
Ponatinib—Upper respiratory tract infection—Topiramate—obesity	0.000219	0.0012	CcSEcCtD
Ponatinib—Insomnia—Sibutramine—obesity	0.000218	0.0012	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000218	0.00119	CcSEcCtD
Ponatinib—Erectile dysfunction—Topiramate—obesity	0.000217	0.00119	CcSEcCtD
Ponatinib—Decreased appetite—Orlistat—obesity	0.000216	0.00119	CcSEcCtD
Ponatinib—Paraesthesia—Sibutramine—obesity	0.000216	0.00119	CcSEcCtD
Ponatinib—CYP3A4—digestive system—obesity	0.000215	0.00181	CbGeAlD
Ponatinib—Gastrointestinal disorder—Orlistat—obesity	0.000215	0.00118	CcSEcCtD
Ponatinib—Dyspnoea—Sibutramine—obesity	0.000215	0.00118	CcSEcCtD
Ponatinib—Fatigue—Orlistat—obesity	0.000215	0.00118	CcSEcCtD
Ponatinib—Dry mouth—Bupropion—obesity	0.000214	0.00118	CcSEcCtD
Ponatinib—CYP3A5—liver—obesity	0.000214	0.00179	CbGeAlD
Ponatinib—Weight decreased—Topiramate—obesity	0.000213	0.00117	CcSEcCtD
Ponatinib—Pain—Orlistat—obesity	0.000213	0.00117	CcSEcCtD
Ponatinib—Hyperglycaemia—Topiramate—obesity	0.000212	0.00117	CcSEcCtD
Ponatinib—Dyspepsia—Sibutramine—obesity	0.000212	0.00116	CcSEcCtD
Ponatinib—CYP2D6—digestive system—obesity	0.000212	0.00178	CbGeAlD
Ponatinib—Pneumonia—Topiramate—obesity	0.000211	0.00116	CcSEcCtD
Ponatinib—Oedema—Bupropion—obesity	0.00021	0.00115	CcSEcCtD
Ponatinib—Infestation NOS—Topiramate—obesity	0.00021	0.00115	CcSEcCtD
Ponatinib—Infestation—Topiramate—obesity	0.00021	0.00115	CcSEcCtD
Ponatinib—Decreased appetite—Sibutramine—obesity	0.000209	0.00115	CcSEcCtD
Ponatinib—Infection—Bupropion—obesity	0.000209	0.00115	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Sibutramine—obesity	0.000208	0.00114	CcSEcCtD
Ponatinib—Pain—Sibutramine—obesity	0.000206	0.00113	CcSEcCtD
Ponatinib—Constipation—Sibutramine—obesity	0.000206	0.00113	CcSEcCtD
Ponatinib—Nervous system disorder—Bupropion—obesity	0.000206	0.00113	CcSEcCtD
Ponatinib—Neuropathy peripheral—Topiramate—obesity	0.000206	0.00113	CcSEcCtD
Ponatinib—Thrombocytopenia—Bupropion—obesity	0.000206	0.00113	CcSEcCtD
Ponatinib—Stomatitis—Topiramate—obesity	0.000204	0.00112	CcSEcCtD
Ponatinib—Skin disorder—Bupropion—obesity	0.000204	0.00112	CcSEcCtD
Ponatinib—Urinary tract infection—Topiramate—obesity	0.000204	0.00112	CcSEcCtD
Ponatinib—Gastrointestinal pain—Orlistat—obesity	0.000204	0.00112	CcSEcCtD
Ponatinib—Hyperhidrosis—Bupropion—obesity	0.000203	0.00111	CcSEcCtD
Ponatinib—ABCB1—adrenal cortex—obesity	0.000201	0.00169	CbGeAlD
Ponatinib—Epistaxis—Topiramate—obesity	0.000198	0.00109	CcSEcCtD
Ponatinib—Gastrointestinal pain—Sibutramine—obesity	0.000197	0.00108	CcSEcCtD
Ponatinib—Abdominal pain—Orlistat—obesity	0.000197	0.00108	CcSEcCtD
Ponatinib—Body temperature increased—Orlistat—obesity	0.000197	0.00108	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Bupropion—obesity	0.000191	0.00105	CcSEcCtD
Ponatinib—Body temperature increased—Sibutramine—obesity	0.00019	0.00105	CcSEcCtD
Ponatinib—Abdominal pain—Sibutramine—obesity	0.00019	0.00105	CcSEcCtD
Ponatinib—Insomnia—Bupropion—obesity	0.00019	0.00104	CcSEcCtD
Ponatinib—Haemoglobin—Topiramate—obesity	0.000189	0.00104	CcSEcCtD
Ponatinib—Paraesthesia—Bupropion—obesity	0.000189	0.00104	CcSEcCtD
Ponatinib—Haemorrhage—Topiramate—obesity	0.000188	0.00103	CcSEcCtD
Ponatinib—Hypoaesthesia—Topiramate—obesity	0.000187	0.00103	CcSEcCtD
Ponatinib—Dyspnoea—Bupropion—obesity	0.000187	0.00103	CcSEcCtD
Ponatinib—Oedema peripheral—Topiramate—obesity	0.000186	0.00102	CcSEcCtD
Ponatinib—Connective tissue disorder—Topiramate—obesity	0.000185	0.00102	CcSEcCtD
Ponatinib—Dyspepsia—Bupropion—obesity	0.000185	0.00101	CcSEcCtD
Ponatinib—ABCB1—cardiovascular system—obesity	0.000184	0.00154	CbGeAlD
Ponatinib—Decreased appetite—Bupropion—obesity	0.000183	0.001	CcSEcCtD
Ponatinib—Visual impairment—Topiramate—obesity	0.000181	0.000996	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Bupropion—obesity	0.000181	0.000995	CcSEcCtD
Ponatinib—Fatigue—Bupropion—obesity	0.000181	0.000994	CcSEcCtD
Ponatinib—Pain—Bupropion—obesity	0.00018	0.000986	CcSEcCtD
Ponatinib—Constipation—Bupropion—obesity	0.00018	0.000986	CcSEcCtD
Ponatinib—Asthenia—Orlistat—obesity	0.000179	0.000981	CcSEcCtD
Ponatinib—CYP3A4—endocrine gland—obesity	0.000178	0.00149	CbGeAlD
Ponatinib—Pruritus—Orlistat—obesity	0.000176	0.000967	CcSEcCtD
Ponatinib—Eye disorder—Topiramate—obesity	0.000176	0.000966	CcSEcCtD
Ponatinib—CYP2D6—endocrine gland—obesity	0.000175	0.00147	CbGeAlD
Ponatinib—Flushing—Topiramate—obesity	0.000175	0.00096	CcSEcCtD
Ponatinib—Cardiac disorder—Topiramate—obesity	0.000175	0.00096	CcSEcCtD
Ponatinib—Asthenia—Sibutramine—obesity	0.000173	0.000949	CcSEcCtD
Ponatinib—Gastrointestinal pain—Bupropion—obesity	0.000172	0.000943	CcSEcCtD
Ponatinib—Angiopathy—Topiramate—obesity	0.000171	0.000938	CcSEcCtD
Ponatinib—Pruritus—Sibutramine—obesity	0.00017	0.000936	CcSEcCtD
Ponatinib—Diarrhoea—Orlistat—obesity	0.00017	0.000935	CcSEcCtD
Ponatinib—Mediastinal disorder—Topiramate—obesity	0.00017	0.000932	CcSEcCtD
Ponatinib—Chills—Topiramate—obesity	0.000169	0.000928	CcSEcCtD
Ponatinib—Alopecia—Topiramate—obesity	0.000166	0.000914	CcSEcCtD
Ponatinib—Abdominal pain—Bupropion—obesity	0.000166	0.000911	CcSEcCtD
Ponatinib—Body temperature increased—Bupropion—obesity	0.000166	0.000911	CcSEcCtD
Ponatinib—Mental disorder—Topiramate—obesity	0.000165	0.000906	CcSEcCtD
Ponatinib—Diarrhoea—Sibutramine—obesity	0.000165	0.000905	CcSEcCtD
Ponatinib—Dizziness—Orlistat—obesity	0.000165	0.000904	CcSEcCtD
Ponatinib—Erythema—Topiramate—obesity	0.000164	0.0009	CcSEcCtD
Ponatinib—Malnutrition—Topiramate—obesity	0.000164	0.0009	CcSEcCtD
Ponatinib—ABCB1—pituitary gland—obesity	0.000162	0.00136	CbGeAlD
Ponatinib—ABCB1—adipose tissue—obesity	0.000162	0.00136	CbGeAlD
Ponatinib—CYP3A4—liver—obesity	0.00016	0.00135	CbGeAlD
Ponatinib—Imatinib—ALB—obesity	0.00016	0.0212	CrCbGaD
Ponatinib—Dizziness—Sibutramine—obesity	0.000159	0.000875	CcSEcCtD
Ponatinib—Back pain—Topiramate—obesity	0.000159	0.000871	CcSEcCtD
Ponatinib—Vomiting—Orlistat—obesity	0.000158	0.000869	CcSEcCtD
Ponatinib—CYP2D6—liver—obesity	0.000158	0.00132	CbGeAlD
Ponatinib—Muscle spasms—Topiramate—obesity	0.000158	0.000865	CcSEcCtD
Ponatinib—Rash—Orlistat—obesity	0.000157	0.000862	CcSEcCtD
Ponatinib—Dermatitis—Orlistat—obesity	0.000157	0.000861	CcSEcCtD
Ponatinib—Headache—Orlistat—obesity	0.000156	0.000856	CcSEcCtD
Ponatinib—Vision blurred—Topiramate—obesity	0.000154	0.000848	CcSEcCtD
Ponatinib—Vomiting—Sibutramine—obesity	0.000153	0.000841	CcSEcCtD
Ponatinib—ABCB1—digestive system—obesity	0.000152	0.00128	CbGeAlD
Ponatinib—Rash—Sibutramine—obesity	0.000152	0.000834	CcSEcCtD
Ponatinib—Dermatitis—Sibutramine—obesity	0.000152	0.000833	CcSEcCtD
Ponatinib—Anaemia—Topiramate—obesity	0.000152	0.000832	CcSEcCtD
Ponatinib—Headache—Sibutramine—obesity	0.000151	0.000829	CcSEcCtD
Ponatinib—Asthenia—Bupropion—obesity	0.000151	0.000827	CcSEcCtD
Ponatinib—Pruritus—Bupropion—obesity	0.000149	0.000816	CcSEcCtD
Ponatinib—Nausea—Orlistat—obesity	0.000148	0.000812	CcSEcCtD
Ponatinib—Leukopenia—Topiramate—obesity	0.000147	0.000806	CcSEcCtD
Ponatinib—ABCB1—adrenal gland—obesity	0.000145	0.00122	CbGeAlD
Ponatinib—Diarrhoea—Bupropion—obesity	0.000144	0.000789	CcSEcCtD
Ponatinib—Nausea—Sibutramine—obesity	0.000143	0.000786	CcSEcCtD
Ponatinib—Cough—Topiramate—obesity	0.000143	0.000785	CcSEcCtD
Ponatinib—Hypertension—Topiramate—obesity	0.000142	0.000777	CcSEcCtD
Ponatinib—Arthralgia—Topiramate—obesity	0.00014	0.000766	CcSEcCtD
Ponatinib—Myalgia—Topiramate—obesity	0.00014	0.000766	CcSEcCtD
Ponatinib—Dizziness—Bupropion—obesity	0.000139	0.000762	CcSEcCtD
Ponatinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000139	0.000761	CcSEcCtD
Ponatinib—Dry mouth—Topiramate—obesity	0.000136	0.000749	CcSEcCtD
Ponatinib—Oedema—Topiramate—obesity	0.000134	0.000735	CcSEcCtD
Ponatinib—Vomiting—Bupropion—obesity	0.000134	0.000733	CcSEcCtD
Ponatinib—Infection—Topiramate—obesity	0.000133	0.00073	CcSEcCtD
Ponatinib—Rash—Bupropion—obesity	0.000132	0.000727	CcSEcCtD
Ponatinib—Dermatitis—Bupropion—obesity	0.000132	0.000726	CcSEcCtD
Ponatinib—Headache—Bupropion—obesity	0.000132	0.000722	CcSEcCtD
Ponatinib—Nervous system disorder—Topiramate—obesity	0.000131	0.00072	CcSEcCtD
Ponatinib—Thrombocytopenia—Topiramate—obesity	0.000131	0.000719	CcSEcCtD
Ponatinib—Skin disorder—Topiramate—obesity	0.00013	0.000714	CcSEcCtD
Ponatinib—Hyperhidrosis—Topiramate—obesity	0.000129	0.00071	CcSEcCtD
Ponatinib—ABCB1—endocrine gland—obesity	0.000126	0.00106	CbGeAlD
Ponatinib—Nausea—Bupropion—obesity	0.000125	0.000685	CcSEcCtD
Ponatinib—Musculoskeletal discomfort—Topiramate—obesity	0.000122	0.000669	CcSEcCtD
Ponatinib—Insomnia—Topiramate—obesity	0.000121	0.000664	CcSEcCtD
Ponatinib—Paraesthesia—Topiramate—obesity	0.00012	0.00066	CcSEcCtD
Ponatinib—Dyspnoea—Topiramate—obesity	0.000119	0.000655	CcSEcCtD
Ponatinib—Dyspepsia—Topiramate—obesity	0.000118	0.000647	CcSEcCtD
Ponatinib—Decreased appetite—Topiramate—obesity	0.000116	0.000639	CcSEcCtD
Ponatinib—Gastrointestinal disorder—Topiramate—obesity	0.000116	0.000634	CcSEcCtD
Ponatinib—Fatigue—Topiramate—obesity	0.000115	0.000633	CcSEcCtD
Ponatinib—Constipation—Topiramate—obesity	0.000114	0.000628	CcSEcCtD
Ponatinib—Pain—Topiramate—obesity	0.000114	0.000628	CcSEcCtD
Ponatinib—ABCB1—liver—obesity	0.000113	0.000952	CbGeAlD
Ponatinib—Gastrointestinal pain—Topiramate—obesity	0.000109	0.000601	CcSEcCtD
Ponatinib—Body temperature increased—Topiramate—obesity	0.000106	0.000581	CcSEcCtD
Ponatinib—Abdominal pain—Topiramate—obesity	0.000106	0.000581	CcSEcCtD
Ponatinib—Asthenia—Topiramate—obesity	9.6e-05	0.000527	CcSEcCtD
Ponatinib—Pruritus—Topiramate—obesity	9.47e-05	0.00052	CcSEcCtD
Ponatinib—Diarrhoea—Topiramate—obesity	9.15e-05	0.000503	CcSEcCtD
Ponatinib—Dizziness—Topiramate—obesity	8.85e-05	0.000486	CcSEcCtD
Ponatinib—Vomiting—Topiramate—obesity	8.51e-05	0.000467	CcSEcCtD
Ponatinib—Rash—Topiramate—obesity	8.44e-05	0.000463	CcSEcCtD
Ponatinib—Dermatitis—Topiramate—obesity	8.43e-05	0.000463	CcSEcCtD
Ponatinib—Headache—Topiramate—obesity	8.38e-05	0.00046	CcSEcCtD
Ponatinib—Nausea—Topiramate—obesity	7.95e-05	0.000436	CcSEcCtD
Ponatinib—SRC—Signaling Pathways—PIK3CG—obesity	1.89e-06	7.52e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—IL6—obesity	1.89e-06	7.51e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—DCN—obesity	1.88e-06	7.49e-06	CbGpPWpGaD
Ponatinib—LYN—Immune System—PIK3CA—obesity	1.88e-06	7.48e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—STAT3—obesity	1.88e-06	7.48e-06	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—PIK3CA—obesity	1.88e-06	7.47e-06	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PTGS2—obesity	1.88e-06	7.47e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PIK3CD—obesity	1.87e-06	7.46e-06	CbGpPWpGaD
Ponatinib—FGFR2—Disease—IL6—obesity	1.87e-06	7.46e-06	CbGpPWpGaD
Ponatinib—FGFR2—Immune System—AKT1—obesity	1.87e-06	7.45e-06	CbGpPWpGaD
Ponatinib—ABL1—Immune System—PIK3CA—obesity	1.87e-06	7.45e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IRS1—obesity	1.87e-06	7.43e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—SERPINE1—obesity	1.85e-06	7.38e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—COMT—obesity	1.85e-06	7.38e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOB—obesity	1.85e-06	7.36e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—STAT3—obesity	1.84e-06	7.35e-06	CbGpPWpGaD
Ponatinib—KIT—Disease—IL6—obesity	1.84e-06	7.33e-06	CbGpPWpGaD
Ponatinib—KIT—Immune System—AKT1—obesity	1.84e-06	7.32e-06	CbGpPWpGaD
Ponatinib—SRC—Adaptive Immune System—AKT1—obesity	1.84e-06	7.31e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CPT1A—obesity	1.83e-06	7.28e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARGC1A—obesity	1.83e-06	7.28e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GNB3—obesity	1.83e-06	7.28e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—MTHFR—obesity	1.82e-06	7.26e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—HMOX1—obesity	1.82e-06	7.24e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TYK2—obesity	1.8e-06	7.18e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—STAT3—obesity	1.8e-06	7.18e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—POMC—obesity	1.8e-06	7.15e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NAMPT—obesity	1.79e-06	7.14e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARA—obesity	1.79e-06	7.13e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—RHOA—obesity	1.79e-06	7.12e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—INS—obesity	1.79e-06	7.11e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LIPC—obesity	1.78e-06	7.1e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GCK—obesity	1.78e-06	7.1e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GNAS—obesity	1.78e-06	7.08e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOC3—obesity	1.77e-06	7.05e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PIK3R1—obesity	1.77e-06	7.05e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—NOS3—obesity	1.77e-06	7.05e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PIK3CG—obesity	1.77e-06	7.05e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—LPL—obesity	1.77e-06	7.03e-06	CbGpPWpGaD
Ponatinib—FGFR3—Signaling Pathways—AKT1—obesity	1.76e-06	7.01e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—CCL2—obesity	1.76e-06	7e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—STAT3—obesity	1.75e-06	6.97e-06	CbGpPWpGaD
Ponatinib—FGFR1—Disease—IL6—obesity	1.75e-06	6.95e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—STAT3—obesity	1.75e-06	6.95e-06	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—PIK3CA—obesity	1.75e-06	6.95e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—MYC—obesity	1.75e-06	6.95e-06	CbGpPWpGaD
Ponatinib—FGFR1—Immune System—AKT1—obesity	1.75e-06	6.95e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOB—obesity	1.74e-06	6.94e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—IL6—obesity	1.74e-06	6.94e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—TGFB1—obesity	1.74e-06	6.93e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Immune System—AKT1—obesity	1.74e-06	6.93e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AGT—obesity	1.73e-06	6.9e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MMP9—obesity	1.73e-06	6.9e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—STAT3—obesity	1.73e-06	6.88e-06	CbGpPWpGaD
Ponatinib—FGFR2—Disease—AKT1—obesity	1.73e-06	6.88e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IGF1—obesity	1.73e-06	6.88e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AKT2—obesity	1.73e-06	6.88e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—GPX1—obesity	1.72e-06	6.86e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CETP—obesity	1.72e-06	6.85e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—MYC—obesity	1.71e-06	6.83e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—TGFB1—obesity	1.71e-06	6.81e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PPARG—obesity	1.71e-06	6.8e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SDC1—obesity	1.7e-06	6.77e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOE—obesity	1.7e-06	6.76e-06	CbGpPWpGaD
Ponatinib—KIT—Disease—AKT1—obesity	1.7e-06	6.76e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MAPK8—obesity	1.68e-06	6.71e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—POMC—obesity	1.68e-06	6.71e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—CAV1—obesity	1.68e-06	6.7e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—APOA1—obesity	1.68e-06	6.69e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CD36—obesity	1.68e-06	6.68e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—MYC—obesity	1.68e-06	6.67e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—INS—obesity	1.68e-06	6.67e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AKR1C3—obesity	1.67e-06	6.66e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—TGFB1—obesity	1.67e-06	6.65e-06	CbGpPWpGaD
Ponatinib—LYN—Immune System—IL6—obesity	1.66e-06	6.63e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—LPL—obesity	1.66e-06	6.62e-06	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—IL6—obesity	1.66e-06	6.62e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PIK3CD—obesity	1.66e-06	6.61e-06	CbGpPWpGaD
Ponatinib—ABL1—Immune System—IL6—obesity	1.66e-06	6.6e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SCARB1—obesity	1.65e-06	6.56e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—SERPINE1—obesity	1.64e-06	6.53e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MTOR—obesity	1.63e-06	6.5e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PIK3CB—obesity	1.63e-06	6.5e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—MYC—obesity	1.63e-06	6.48e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—GPX1—obesity	1.62e-06	6.46e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—TGFB1—obesity	1.62e-06	6.46e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—MYC—obesity	1.62e-06	6.46e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—TGFB1—obesity	1.62e-06	6.45e-06	CbGpPWpGaD
Ponatinib—FGFR1—Disease—AKT1—obesity	1.61e-06	6.41e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.61e-06	6.4e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Disease—AKT1—obesity	1.61e-06	6.4e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SREBF1—obesity	1.6e-06	6.37e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TYK2—obesity	1.6e-06	6.36e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—STAT3—obesity	1.6e-06	6.36e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—MTHFR—obesity	1.59e-06	6.33e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—RHOA—obesity	1.58e-06	6.3e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CD36—obesity	1.58e-06	6.29e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PIK3R1—obesity	1.57e-06	6.24e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—NOS3—obesity	1.57e-06	6.24e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARA—obesity	1.56e-06	6.21e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PIK3CD—obesity	1.56e-06	6.19e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT2—obesity	1.56e-06	6.19e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—PIK3CA—obesity	1.54e-06	6.13e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—STAT3—obesity	1.54e-06	6.13e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—ALB—obesity	1.54e-06	6.12e-06	CbGpPWpGaD
Ponatinib—LYN—Immune System—AKT1—obesity	1.54e-06	6.11e-06	CbGpPWpGaD
Ponatinib—KDR—Signaling Pathways—AKT1—obesity	1.53e-06	6.1e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PIK3CG—obesity	1.53e-06	6.1e-06	CbGpPWpGaD
Ponatinib—ABL1—Immune System—AKT1—obesity	1.53e-06	6.08e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—FASN—obesity	1.52e-06	6.06e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—BCHE—obesity	1.52e-06	6.03e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AGT—obesity	1.51e-06	6.01e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—MTHFR—obesity	1.5e-06	5.96e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—MYC—obesity	1.48e-06	5.91e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—PIK3CA—obesity	1.48e-06	5.9e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOE—obesity	1.48e-06	5.89e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—TGFB1—obesity	1.48e-06	5.89e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PPARG—obesity	1.48e-06	5.89e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARA—obesity	1.47e-06	5.85e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—NOS3—obesity	1.47e-06	5.85e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PIK3R1—obesity	1.47e-06	5.85e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—CAV1—obesity	1.47e-06	5.84e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—APOA1—obesity	1.46e-06	5.82e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP2E1—obesity	1.46e-06	5.82e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—POMC—obesity	1.46e-06	5.81e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—PIK3CA—obesity	1.46e-06	5.79e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—INS—obesity	1.45e-06	5.78e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PIK3CB—obesity	1.45e-06	5.76e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MTOR—obesity	1.45e-06	5.76e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NQO1—obesity	1.45e-06	5.76e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—MYC—obesity	1.43e-06	5.7e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—TGFB1—obesity	1.43e-06	5.68e-06	CbGpPWpGaD
Ponatinib—ABCB11—Metabolism—AKT1—obesity	1.43e-06	5.68e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AGT—obesity	1.42e-06	5.67e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—PIK3CA—obesity	1.42e-06	5.66e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MMP9—obesity	1.42e-06	5.65e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOE—obesity	1.39e-06	5.55e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—SLC2A4—obesity	1.39e-06	5.52e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GCG—obesity	1.39e-06	5.52e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—CAV1—obesity	1.38e-06	5.5e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—PIK3CA—obesity	1.38e-06	5.5e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MAPK8—obesity	1.38e-06	5.5e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—APOA1—obesity	1.38e-06	5.49e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—PIK3CA—obesity	1.38e-06	5.48e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYCS—obesity	1.37e-06	5.45e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—IL6—obesity	1.36e-06	5.43e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—PIK3CA—obesity	1.36e-06	5.43e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PIK3CB—obesity	1.36e-06	5.4e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PIK3CD—obesity	1.35e-06	5.37e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PTGS2—obesity	1.34e-06	5.35e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GOT1—obesity	1.34e-06	5.34e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GGT1—obesity	1.34e-06	5.34e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PIK3CG—obesity	1.34e-06	5.32e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—ALB—obesity	1.33e-06	5.3e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NCOA1—obesity	1.32e-06	5.26e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—IL6—obesity	1.31e-06	5.22e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—STK11—obesity	1.3e-06	5.19e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CYP19A1—obesity	1.3e-06	5.19e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PPARG—obesity	1.29e-06	5.13e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—IL6—obesity	1.29e-06	5.13e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—NOS3—obesity	1.27e-06	5.07e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PIK3R1—obesity	1.27e-06	5.07e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—POMC—obesity	1.27e-06	5.06e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—INS—obesity	1.26e-06	5.03e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—STAT3—obesity	1.26e-06	5.03e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—IL6—obesity	1.26e-06	5.01e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—PIK3CA—obesity	1.26e-06	5.01e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PIK3CG—obesity	1.26e-06	5.01e-06	CbGpPWpGaD
Ponatinib—LCK—Immune System—AKT1—obesity	1.26e-06	5.01e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MMP9—obesity	1.26e-06	5.01e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—IL6—obesity	1.22e-06	4.87e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MAPK8—obesity	1.22e-06	4.87e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—IL6—obesity	1.22e-06	4.86e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—PIK3CA—obesity	1.22e-06	4.84e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PPARG—obesity	1.21e-06	4.84e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—COMT—obesity	1.21e-06	4.82e-06	CbGpPWpGaD
Ponatinib—FGFR2—Signaling Pathways—AKT1—obesity	1.21e-06	4.82e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—IL6—obesity	1.21e-06	4.81e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—POMC—obesity	1.2e-06	4.77e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GNB3—obesity	1.19e-06	4.76e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARGC1A—obesity	1.19e-06	4.76e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—INS—obesity	1.19e-06	4.74e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—HMOX1—obesity	1.19e-06	4.73e-06	CbGpPWpGaD
Ponatinib—KIT—Signaling Pathways—AKT1—obesity	1.19e-06	4.73e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PIK3CB—obesity	1.17e-06	4.68e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PIK3CD—obesity	1.17e-06	4.67e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—MYC—obesity	1.17e-06	4.67e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—TGFB1—obesity	1.17e-06	4.66e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PTGS2—obesity	1.16e-06	4.63e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GNAS—obesity	1.16e-06	4.63e-06	CbGpPWpGaD
Ponatinib—LCK—Disease—AKT1—obesity	1.16e-06	4.63e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—ALB—obesity	1.16e-06	4.61e-06	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—PIK3CA—obesity	1.15e-06	4.59e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOB—obesity	1.14e-06	4.54e-06	CbGpPWpGaD
Ponatinib—FGFR1—Signaling Pathways—AKT1—obesity	1.13e-06	4.49e-06	CbGpPWpGaD
Ponatinib—PDGFRA—Signaling Pathways—AKT1—obesity	1.13e-06	4.48e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—STAT3—obesity	1.12e-06	4.45e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—IL6—obesity	1.11e-06	4.44e-06	CbGpPWpGaD
Ponatinib—SRC—Immune System—AKT1—obesity	1.11e-06	4.44e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PIK3R1—obesity	1.11e-06	4.41e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—NOS3—obesity	1.11e-06	4.41e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PIK3CD—obesity	1.11e-06	4.4e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—ALB—obesity	1.09e-06	4.35e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—LPL—obesity	1.09e-06	4.33e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—IL6—obesity	1.08e-06	4.28e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—GPX1—obesity	1.06e-06	4.23e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—NOS3—obesity	1.04e-06	4.16e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PIK3R1—obesity	1.04e-06	4.16e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—MYC—obesity	1.04e-06	4.14e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—TGFB1—obesity	1.04e-06	4.13e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CD36—obesity	1.03e-06	4.11e-06	CbGpPWpGaD
Ponatinib—SRC—Disease—AKT1—obesity	1.03e-06	4.1e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PIK3CB—obesity	1.02e-06	4.07e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PTGS2—obesity	1.01e-06	4.04e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—PIK3CA—obesity	9.96e-07	3.97e-06	CbGpPWpGaD
Ponatinib—LYN—Signaling Pathways—AKT1—obesity	9.93e-07	3.95e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—MTHFR—obesity	9.79e-07	3.9e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PIK3CB—obesity	9.64e-07	3.84e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARA—obesity	9.61e-07	3.83e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PTGS2—obesity	9.56e-07	3.8e-06	CbGpPWpGaD
Ponatinib—ABCG2—Metabolism—AKT1—obesity	9.43e-07	3.75e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AGT—obesity	9.31e-07	3.7e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOE—obesity	9.12e-07	3.63e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—CAV1—obesity	9.03e-07	3.6e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—APOA1—obesity	9.01e-07	3.59e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—IL6—obesity	8.82e-07	3.51e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—PIK3CA—obesity	8.82e-07	3.51e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—PIK3CA—obesity	8.27e-07	3.29e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PIK3CG—obesity	8.23e-07	3.28e-06	CbGpPWpGaD
Ponatinib—LCK—Signaling Pathways—AKT1—obesity	8.14e-07	3.24e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PPARG—obesity	7.94e-07	3.16e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—POMC—obesity	7.83e-07	3.12e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—IL6—obesity	7.81e-07	3.11e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—INS—obesity	7.79e-07	3.1e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PIK3CD—obesity	7.23e-07	2.88e-06	CbGpPWpGaD
Ponatinib—SRC—Signaling Pathways—AKT1—obesity	7.2e-07	2.87e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—PIK3CA—obesity	7.16e-07	2.85e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—ALB—obesity	7.14e-07	2.84e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—NOS3—obesity	6.83e-07	2.72e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PIK3R1—obesity	6.83e-07	2.72e-06	CbGpPWpGaD
Ponatinib—CYP3A5—Metabolism—AKT1—obesity	6.75e-07	2.69e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PIK3CB—obesity	6.3e-07	2.51e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PTGS2—obesity	6.25e-07	2.49e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—PIK3CA—obesity	6.24e-07	2.48e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—PIK3CA—obesity	5.88e-07	2.34e-06	CbGpPWpGaD
Ponatinib—CYP2C8—Metabolism—AKT1—obesity	5.85e-07	2.33e-06	CbGpPWpGaD
Ponatinib—ABCB1—Metabolism—AKT1—obesity	5.1e-07	2.03e-06	CbGpPWpGaD
Ponatinib—CYP2D6—Metabolism—AKT1—obesity	4.8e-07	1.91e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—PIK3CA—obesity	3.84e-07	1.53e-06	CbGpPWpGaD
Ponatinib—CYP3A4—Metabolism—AKT1—obesity	3.14e-07	1.25e-06	CbGpPWpGaD
